These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 16505172)

  • 1. Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis.
    Leger AJ; Jacques SL; Badar J; Kaneider NC; Derian CK; Andrade-Gordon P; Covic L; Kuliopulos A
    Circulation; 2006 Mar; 113(9):1244-54. PubMed ID: 16505172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
    Wu CC; Teng CM
    Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated receptor 1 (PAR1) and PAR4 heterodimers are required for PAR1-enhanced cleavage of PAR4 by α-thrombin.
    Arachiche A; Mumaw MM; de la Fuente M; Nieman MT
    J Biol Chem; 2013 Nov; 288(45):32553-32562. PubMed ID: 24097976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant and antithrombotic properties of intracellular protease-activated receptor antagonists.
    Wielders SJ; Bennaghmouch A; Reutelingsperger CP; Bevers EM; Lindhout T
    J Thromb Haemost; 2007 Mar; 5(3):571-6. PubMed ID: 17166251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets.
    Duvernay MT; Temple KJ; Maeng JG; Blobaum AL; Stauffer SR; Lindsley CW; Hamm HE
    Mol Pharmacol; 2017 Jan; 91(1):39-47. PubMed ID: 27784794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.
    French SL; Arthur JF; Lee H; Nesbitt WS; Andrews RK; Gardiner EE; Hamilton JR
    J Thromb Haemost; 2016 Aug; 14(8):1642-54. PubMed ID: 26878340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
    Kahn ML; Nakanishi-Matsui M; Shapiro MJ; Ishihara H; Coughlin SR
    J Clin Invest; 1999 Mar; 103(6):879-87. PubMed ID: 10079109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
    Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL
    J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions.
    Hosokawa K; Ohnishi T; Miura N; Sameshima H; Koide T; Tanaka KA; Maruyama I
    Thromb Res; 2014 Jan; 133(1):66-72. PubMed ID: 24268424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation.
    Holinstat M; Voss B; Bilodeau ML; McLaughlin JN; Cleator J; Hamm HE
    J Biol Chem; 2006 Sep; 281(36):26665-74. PubMed ID: 16837456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
    Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
    Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets.
    Covic L; Gresser AL; Kuliopulos A
    Biochemistry; 2000 May; 39(18):5458-67. PubMed ID: 10820018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact.
    Judge HM; Jennings LK; Moliterno DJ; Hord E; Ecob R; Tricoci P; Rorick T; Kotha J; Storey RF
    Platelets; 2015; 26(3):236-42. PubMed ID: 24750101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined blockade of thrombin anion binding exosite-1 and PAR4 produces synergistic antiplatelet effect in human platelets.
    Wu CC; Wang WY; Wei CK; Teng CM
    Thromb Haemost; 2011 Jan; 105(1):88-95. PubMed ID: 21057701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid Receptor GPR31 (G-Protein-Coupled Receptor 31) Regulates Platelet Reactivity and Thrombosis Without Affecting Hemostasis.
    Van Doren L; Nguyen N; Garzia C; Fletcher EK; Stevenson R; Jaramillo D; Kuliopulos A; Covic L
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e33-e45. PubMed ID: 33267659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions.
    Lee H; Sturgeon SA; Jackson SP; Hamilton JR
    Thromb Haemost; 2012 Feb; 107(2):328-37. PubMed ID: 22187047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets.
    Chen WF; Lee JJ; Chang CC; Lin KH; Wang SH; Sheu JR
    Haematologica; 2013 May; 98(5):793-801. PubMed ID: 23065519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systems biology insights into the meaning of the platelet's dual-receptor thrombin signaling.
    Sveshnikova AN; Balatskiy AV; Demianova AS; Shepelyuk TO; Shakhidzhanov SS; Balatskaya MN; Pichugin AV; Ataullakhanov FI; Panteleev MA
    J Thromb Haemost; 2016 Oct; 14(10):2045-2057. PubMed ID: 27513817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dichotomous effects of exposure to bivalirudin in patients undergoing percutaneous coronary intervention on protease-activated receptor-mediated platelet activation.
    Holinstat M; Colowick NE; Hudson WJ; Blakemore D; Chen Q; Hamm HE; Cleator JH
    J Thromb Thrombolysis; 2013 Feb; 35(2):209-22. PubMed ID: 23054462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin induces platelet activation in the absence of functional protease activated receptors 1 and 4 and glycoprotein Ib-IX-V.
    Lova P; Canobbio I; Guidetti GF; Balduini C; Torti M
    Cell Signal; 2010 Nov; 22(11):1681-7. PubMed ID: 20600849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.